Kalika Kamat1, Venkatesh Krishnan1, Oliver Dorigo2. 1. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford Women's Cancer Center, Stanford Cancer Institute, Stanford, CA, USA. 2. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford Women's Cancer Center, Stanford Cancer Institute, Stanford, CA, USA. odorigo@stanford.edu.
Abstract
BACKGROUND: Macrophages are an important component of the tumour immune microenvironment (TME) and can promote tumour growth and metastasis. Macrophage-secreted chemokine-ligand-23 (CCL23) induces ovarian cancer cell migration via chemokine-receptor 1 (CCR1). However, the effect of CCL23 on other immune cells in the TME is unknown. METHODS: CCL23 levels were measured by ELISA. The expression of surface markers in exhaustion assays was quantified by flow cytometry. Signalling pathways were identified by phosphokinase array and validated by western blot. RESULTS: Ascites from patients with high-grade serous ovarian cancer (HGSC) contain high levels of CCL23. Similarly, significantly higher CCL23 levels were found in plasma from HGSC patients compared to healthy individuals. RNA-seq analysis of ovarian cancer tissues from TCGA showed that expression of CCL23 correlated with the presence of macrophages. In tissues with high levels of CCL23 and macrophage content, the fraction of CD8 + T cells expressing exhaustion markers CTLA-4 and PD-1 were significantly higher compared to low-level CCL23 tissues. In vitro, CCL23 induced upregulation of immune checkpoint proteins on CD8 + T cells, including CTLA-4, TIGIT, TIM-3 and LAG-3 via phosphorylation of GSK3β in CD8 + T cells. CONCLUSIONS: Our data suggest that CCL23 produced by macrophages contributes to the immune-suppressive TME in ovarian cancer by inducing an exhausted T-cell phenotype.
BACKGROUND: Macrophages are an important component of the tumour immune microenvironment (TME) and can promote tumour growth and metastasis. Macrophage-secreted chemokine-ligand-23 (CCL23) induces ovarian cancer cell migration via chemokine-receptor 1 (CCR1). However, the effect of CCL23 on other immune cells in the TME is unknown. METHODS: CCL23 levels were measured by ELISA. The expression of surface markers in exhaustion assays was quantified by flow cytometry. Signalling pathways were identified by phosphokinase array and validated by western blot. RESULTS: Ascites from patients with high-grade serous ovarian cancer (HGSC) contain high levels of CCL23. Similarly, significantly higher CCL23 levels were found in plasma from HGSC patients compared to healthy individuals. RNA-seq analysis of ovarian cancer tissues from TCGA showed that expression of CCL23 correlated with the presence of macrophages. In tissues with high levels of CCL23 and macrophage content, the fraction of CD8 + T cells expressing exhaustion markers CTLA-4 and PD-1 were significantly higher compared to low-level CCL23 tissues. In vitro, CCL23 induced upregulation of immune checkpoint proteins on CD8 + T cells, including CTLA-4, TIGIT, TIM-3 and LAG-3 via phosphorylation of GSK3β in CD8 + T cells. CONCLUSIONS: Our data suggest that CCL23 produced by macrophages contributes to the immune-suppressive TME in ovarian cancer by inducing an exhausted T-cell phenotype.
Authors: Qi Cao; Yiping Wang; Dong Zheng; Yan Sun; Ya Wang; Vincent W S Lee; Guoping Zheng; Thian Kui Tan; Jon Ince; Stephen I Alexander; David C H Harris Journal: J Am Soc Nephrol Date: 2010-03-18 Impact factor: 10.121
Authors: Allen W Zhang; Andrew McPherson; Katy Milne; David R Kroeger; Phineas T Hamilton; Alex Miranda; Tyler Funnell; Nicole Little; Camila P E de Souza; Sonya Laan; Stacey LeDoux; Dawn R Cochrane; Jamie L P Lim; Winnie Yang; Andrew Roth; Maia A Smith; Julie Ho; Kane Tse; Thomas Zeng; Inna Shlafman; Michael R Mayo; Richard Moore; Henrik Failmezger; Andreas Heindl; Yi Kan Wang; Ali Bashashati; Diljot S Grewal; Scott D Brown; Daniel Lai; Adrian N C Wan; Cydney B Nielsen; Curtis Huebner; Basile Tessier-Cloutier; Michael S Anglesio; Alexandre Bouchard-Côté; Yinyin Yuan; Wyeth W Wasserman; C Blake Gilks; Anthony N Karnezis; Samuel Aparicio; Jessica N McAlpine; David G Huntsman; Robert A Holt; Brad H Nelson; Sohrab P Shah Journal: Cell Date: 2018-05-10 Impact factor: 41.582
Authors: Melissa J Conroy; Karen C Galvin; Maria E Kavanagh; Ann Marie Mongan; Suzanne L Doyle; Niamh Gilmartin; Cliona O'Farrelly; John V Reynolds; Joanne Lysaght Journal: Immunol Cell Biol Date: 2016-04-05 Impact factor: 5.126